4
Changes in Ownership
Arcadia Biosciences, Inc. Filed Acc 0001209191-21-005219
Chief Executive Officer bought 585 shares at $3.16 ($1,849)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Plavan Matthew T Chief Executive Officer | 2020-08-03 | Purchase | +585 | $3.16 | $1,849 | 14,285 | D |
| Derivatives | |||||||
| Plavan Matthew T Chief Executive Officer | 2021-01-21 | Grant or award · Stock Option (right to buy) | +250,000 | 435,450 | D | ||
| Open-market purchases · 585 sh · avg $3.16 · $1,849 | |||||||
Loading xslF345X03/doc4.xml…